Home › Companies › MADRIGAL PHARMACEUTICALS INC. › 2023-2024
Compiled from SEC Form N-PX filings and MADRIGAL PHARMACEUTICALS INC.’s Form 8-K, filed 2024-06-27 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore MADRIGAL PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are MADRIGAL PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-27 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Bill Sibold | 16,222,905 | -- | -- | 154,896 | 2,188,174 | Majority: yes |
| Elect Director: Rebecca Taub, M.D. | 16,045,750 | -- | -- | 332,051 | 2,188,174 | Majority: yes |
| Elect Director: Fred B. Craves, Ph.D. | 14,311,451 | -- | -- | 2,066,303 | 2,188,221 | Majority: yes |
| Proposal 2: The Company's stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. | 18,444,828 | 110,517 | 10,630 | -- | -- | Majority: yes |
| Proposal 3: The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as described in the Proxy Statement. | 15,585,020 | 781,212 | 11,522 | -- | 2,188,221 | Majority: yes |
| Proposal 4: The Company's stockholders approved an amendment to the Madrigal Pharmaceuticals, Inc. 2015 Amended Stock Plan to increase the total number of shares of common stock available for issuance by 750,000 and extend its duration by 10 years until April | 15,941,045 | 428,537 | 8,219 | -- | 2,188,174 | Majority: yes |
Source: MADRIGAL PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2024-06-27 — read the filing on EDGAR.
Each item below shows how the 288 asset managers that disclosed a MADRIGAL PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 8 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
MADRIGAL PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as described in the Proxy Statement.”): 15,585,020 for, 781,212 against, per its Form 8-K filed 2024-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,875,427 outstanding shares: 78% for, 4% against (82% of the company cast a for/against vote).
The 285 asset managers below cast 94% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 2,487,193 | 0 | 0 | 0 | For |
| BAKER BROS. ADVISORS LP | 1,969,798 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,772,021 | 0 | 0 | 0 | For |
| Vanguard | 1,637,163 | 78,989 | 0 | 0 | For |
| T. Rowe Price | 1,329,021 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 923,102 | 0 | 0 | 0 | For |
| BlackRock | 753,993 | 1,976 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 536,622 | 0 | 0 | 0 | For |
| Artisan | 517,473 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 420,953 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 285,931 | 0 | 0 | 0 | For |
| State Street | 255,252 | 35 | 0 | 0 | For |
| Charles Schwab | 0 | 247,324 | 0 | 0 | Against |
| Fidelity | 223,458 | 304 | 0 | 0 | For |
| Bain Capital Life Sciences Investors, LLC | 196,995 | 0 | 0 | 0 | For |
| American Century | 0 | 185,301 | 0 | 0 | Against |
| ARMISTICE CAPITAL, LLC | 175,883 | 0 | 0 | 0 | For |
| TCG Crossover Management, LLC | 149,283 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 125,365 | 0 | 0 | 0 | For |
| ArrowMark Colorado Holdings LLC | 0 | 98,806 | 0 | 0 | Against |
| Ensign Peak Advisors, Inc | 91,042 | 0 | 0 | 0 | For |
| Invesco | 81,106 | 0 | 0 | 0 | For |
| EcoR1 Capital, LLC | 75,000 | 0 | 0 | 0 | For |
| Northern Trust | 70,022 | 10 | 0 | 0 | For |
| Nuveen | 68,680 | 0 | 0 | 0 | For |
Showing the 25 largest of 285 asset managers. See all 285 in the interactive database.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
MADRIGAL PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: The Company's stockholders approved an amendment to the Madrigal Pharmaceuticals, Inc. 2015 Amended Stock Plan to increase the total number of shares of common stock available for issuance by 750,000 and exte”): 15,941,045 for, 428,537 against, per its Form 8-K filed 2024-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,875,427 outstanding shares: 80% for, 2% against (82% of the company cast a for/against vote).
The 80 asset managers below cast 98% of the shares they voted on this item FOR (5,704,196 for, 100,622 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 1,772,021 | 0 | 0 | 0 | For |
| Vanguard | 1,675,430 | 0 | 0 | 0 | For |
| T. Rowe Price | 587,672 | 0 | 0 | 0 | For |
| BlackRock | 390,103 | 0 | 0 | 0 | For |
| Artisan | 251,283 | 0 | 0 | 0 | For |
| Charles Schwab | 123,656 | 0 | 0 | 0 | For |
| American Century | 0 | 91,230 | 0 | 0 | Against |
| Fidelity | 76,653 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 54,469 | 0 | 0 | 0 | For |
| Lord Abbett | 54,435 | 0 | 0 | 0 | For |
| TIAA | 49,103 | 0 | 0 | 0 | For |
| JANUS ASPEN SERIES | 42,402 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 38,632 | 0 | 0 | 0 | For |
| Brighthouse | 36,133 | 0 | 884 | 0 | For |
| Pacific Life | 36,870 | 0 | 0 | 0 | For |
| Invesco | 35,339 | 0 | 0 | 0 | For |
| State Street | 31,124 | 5 | 0 | 0 | For |
| Equitable | 30,800 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 30,140 | 0 | 0 | 0 | For |
| Principal | 28,926 | 0 | 0 | 0 | For |
| Jackson National | 27,935 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,143 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 23,294 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 23,016 | 0 | 0 | 0 | For |
| Waddell & Reed | 22,182 | 0 | 0 | 0 | For |
Showing the 25 largest of 80 asset managers. See all 80 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
MADRIGAL PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: The Company's stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”): 18,444,828 for, 110,517 against, per its Form 8-K filed 2024-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,875,427 outstanding shares: 93% for, 0.6% against (93% of the company cast a for/against vote).
The 80 asset managers below cast 99.9% of the shares they voted on this item FOR (5,802,154 for, 2,664 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 1,772,021 | 0 | 0 | 0 | For |
| Vanguard | 1,675,430 | 0 | 0 | 0 | For |
| T. Rowe Price | 587,672 | 0 | 0 | 0 | For |
| BlackRock | 390,103 | 0 | 0 | 0 | For |
| Artisan | 251,283 | 0 | 0 | 0 | For |
| Charles Schwab | 123,656 | 0 | 0 | 0 | For |
| American Century | 91,230 | 0 | 0 | 0 | For |
| Fidelity | 76,653 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 54,469 | 0 | 0 | 0 | For |
| Lord Abbett | 54,435 | 0 | 0 | 0 | For |
| TIAA | 49,103 | 0 | 0 | 0 | For |
| JANUS ASPEN SERIES | 42,402 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 38,632 | 0 | 0 | 0 | For |
| Brighthouse | 36,133 | 0 | 884 | 0 | For |
| Pacific Life | 36,870 | 0 | 0 | 0 | For |
| Invesco | 35,339 | 0 | 0 | 0 | For |
| State Street | 31,124 | 5 | 0 | 0 | For |
| Equitable | 30,800 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 30,140 | 0 | 0 | 0 | For |
| Principal | 28,926 | 0 | 0 | 0 | For |
| Jackson National | 27,935 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,143 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 23,294 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 23,016 | 0 | 0 | 0 | For |
| Waddell & Reed | 22,182 | 0 | 0 | 0 | For |
Showing the 25 largest of 80 asset managers. See all 80 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
MADRIGAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Bill Sibold”): 16,222,905 for, 154,896 withheld, per its Form 8-K filed 2024-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,875,427 outstanding shares: 82% for, 0.8% withheld (82% of the company cast a for/withheld vote).
The 79 asset managers below cast 100% of the shares they voted on this item FOR (5,715,165 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 1,772,021 | 0 | 0 | 0 | For |
| Vanguard | 1,675,430 | 0 | 0 | 0 | For |
| T. Rowe Price | 587,672 | 0 | 0 | 0 | For |
| BlackRock | 390,103 | 0 | 0 | 0 | For |
| Artisan | 251,283 | 0 | 0 | 0 | For |
| Charles Schwab | 123,656 | 0 | 0 | 0 | For |
| American Century | 91,230 | 0 | 0 | 0 | For |
| Fidelity | 76,653 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 54,469 | 0 | 0 | 0 | For |
| Lord Abbett | 54,435 | 0 | 0 | 0 | For |
| TIAA | 49,103 | 0 | 0 | 0 | For |
| JANUS ASPEN SERIES | 42,402 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 0 | 0 | 38,632 | 0 | Abstain |
| Brighthouse | 36,133 | 0 | 884 | 0 | For |
| Pacific Life | 36,870 | 0 | 0 | 0 | For |
| Invesco | 35,339 | 0 | 0 | 0 | For |
| State Street | 31,129 | 0 | 0 | 0 | For |
| Equitable | 30,800 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 30,140 | 0 | 0 | 0 | For |
| Principal | 1,732 | 0 | 27,194 | 0 | Abstain |
| Jackson National | 27,935 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,143 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 23,016 | 0 | 0 | 0 | For |
| Waddell & Reed | 22,182 | 0 | 0 | 0 | For |
| ALGER FUNDS II | 20,392 | 0 | 0 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 4 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
MADRIGAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Fred B. Craves, Ph.D.”): 14,311,451 for, 2,066,303 withheld, per its Form 8-K filed 2024-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,875,427 outstanding shares: 72% for, 10% withheld (82% of the company cast a for/withheld vote).
The 79 asset managers below cast 100% of the shares they voted on this item FOR (4,729,985 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 1,772,021 | 0 | 0 | 0 | For |
| Vanguard | 1,596,441 | 0 | 78,989 | 0 | For |
| T. Rowe Price | 587,672 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 390,103 | 0 | Abstain |
| Artisan | 251,283 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 123,656 | 0 | Abstain |
| American Century | 91,230 | 0 | 0 | 0 | For |
| Fidelity | 70,387 | 0 | 6,266 | 0 | For |
| OLD WESTBURY FUNDS INC | 54,469 | 0 | 0 | 0 | For |
| Lord Abbett | 54,435 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 49,103 | 0 | Abstain |
| JANUS ASPEN SERIES | 42,402 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 0 | 0 | 38,632 | 0 | Abstain |
| Brighthouse | 981 | 0 | 36,036 | 0 | Abstain |
| Pacific Life | 31,865 | 0 | 5,005 | 0 | For |
| Invesco | 0 | 0 | 35,339 | 0 | Abstain |
| State Street | 67 | 0 | 31,062 | 0 | Abstain |
| Equitable | 3,090 | 0 | 27,710 | 0 | Abstain |
| Delaware/Macquarie | 0 | 0 | 30,140 | 0 | Abstain |
| Principal | 1,732 | 0 | 27,194 | 0 | Abstain |
| Jackson National | 0 | 0 | 27,935 | 0 | Abstain |
| AIG/SunAmerica | 26,143 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 23,016 | 0 | 0 | 0 | For |
| Waddell & Reed | 0 | 0 | 22,182 | 0 | Abstain |
| ALGER FUNDS II | 0 | 0 | 20,392 | 0 | Abstain |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
MADRIGAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Rebecca Taub, M.D.”): 16,045,750 for, 332,051 withheld, per its Form 8-K filed 2024-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,875,427 outstanding shares: 81% for, 2% withheld (82% of the company cast a for/withheld vote).
The 79 asset managers below cast 100% of the shares they voted on this item FOR (5,671,061 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 1,772,021 | 0 | 0 | 0 | For |
| Vanguard | 1,675,430 | 0 | 0 | 0 | For |
| T. Rowe Price | 587,672 | 0 | 0 | 0 | For |
| BlackRock | 390,103 | 0 | 0 | 0 | For |
| Artisan | 251,283 | 0 | 0 | 0 | For |
| Charles Schwab | 123,656 | 0 | 0 | 0 | For |
| American Century | 91,230 | 0 | 0 | 0 | For |
| Fidelity | 76,653 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 54,469 | 0 | 0 | 0 | For |
| Lord Abbett | 54,435 | 0 | 0 | 0 | For |
| TIAA | 49,103 | 0 | 0 | 0 | For |
| JANUS ASPEN SERIES | 42,402 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 0 | 0 | 38,632 | 0 | Abstain |
| Brighthouse | 36,133 | 0 | 884 | 0 | For |
| Pacific Life | 36,870 | 0 | 0 | 0 | For |
| Invesco | 35,339 | 0 | 0 | 0 | For |
| State Street | 72 | 0 | 31,057 | 0 | Abstain |
| Equitable | 30,800 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 30,140 | 0 | 0 | 0 | For |
| Principal | 1,732 | 0 | 27,194 | 0 | Abstain |
| Jackson National | 27,935 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,143 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 23,016 | 0 | 0 | 0 | For |
| Waddell & Reed | 22,182 | 0 | 0 | 0 | For |
| ALGER FUNDS II | 20,392 | 0 | 0 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Ranked by the number of MADRIGAL PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 19,875,427 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Janus Henderson | 12.51% |
| 2 | BAKER BROS. ADVISORS LP | 9.91% |
| 3 | JANUS INVESTMENT FUND | 8.92% |
| 4 | Vanguard | 8.63% |
| 5 | T. Rowe Price | 6.69% |
| 6 | Avoro Capital Advisors LLC | 4.64% |
| 7 | BlackRock | 3.80% |
| 8 | RTW INVESTMENTS, LP | 2.70% |
| 9 | Artisan | 2.60% |
| 10 | RA CAPITAL MANAGEMENT, L.P. | 2.12% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Entities Affiliated with Janus Henderson Group plc | 14.60% | DEF14A |
| Entities Affiliated with Avoro Capital Advisors LLC | 10.79% | DEF14A |
| Entities Affiliated with Baker Bros. Advisors LP | 10.79% | DEF14A |
| Julian Baker | 10.79% | DEF14A |
| Paul A. Friedman, M.D. | 10.35% | DEF14A |
| Rebecca Taub, M.D. | 10.35% | DEF14A |
| Vanguard Group | 9.12% | 13F |
| Entities Affiliated with The Vanguard Group | 7.92% | DEF14A |
| BlackRock | 7.85% | 13F |
| Entities Affiliated with BlackRock, Inc. | 6.10% | DEF14A |
Percentages above are of 19,875,427 shares outstanding, as reported by MADRIGAL PHARMACEUTICALS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MADRIGAL PHARMACEUTICALS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At MADRIGAL PHARMACEUTICALS INC.'s shareholder meeting held 2024-06-25, in the 2023-2024 proxy season, 288 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 1,845 separate fund positions. On the most widely held item on that ballot — Advisory vote to approve executive compensation. — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: MADRIGAL PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-27.
MADRIGAL PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.